JMML is a pathology depicted by a very low gene mutation frequency as compared to other neoplasms such as CMML; somatic or germline RAS pathway involvement occurs in 89% of cases, and frequently, secondary alterations involve SETBP1 and JAK3 genes. Here, SETBP1 is linked to neoplasm.